CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 20,362 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 30,000 shares (option exercise)
- 4 Planned sale President and CEO sold 21,000 shares at $15.16 ($318,360)
- 144 Insider Sale of Securities
- 4 Open-market sale COO and SVP, Compliance sold 10,096 shares at $15.63 ($157,800)
- 4 Shares withheld for taxes President and CEO gave up 85,951 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 14,000 shares at an average $15.53 ($217,420)
- 4 Shares withheld for taxes President and CEO gave up 54,858 shares (to pay taxes)
- 8-K Event Regulation FD disclosure · Other events
- 3 Insider Initial Statement of Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations · Executive or director change
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 8,161 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 24,793 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 6,479 shares (to pay taxes)
- 4 Planned sale President and CEO sold 21,000 shares at $16.08 ($337,680)
Page 2 of 50 · 1,000 filings